CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Down 88.5% in May

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) was the recipient of a significant drop in short interest in May. As of May 29th, there was short interest totaling 293,249 shares, a drop of 88.5% from the May 14th total of 2,549,897 shares. Based on an average daily trading volume, of 39,007,375 shares, the days-to-cover ratio is presently 0.0 days.

CNBX Pharmaceuticals Stock Performance

CNBX Pharmaceuticals stock remained flat at $0.00 during trading on Tuesday. The company had a trading volume of 3,610,023 shares, compared to its average volume of 34,504,793. CNBX Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $0.01.

About CNBX Pharmaceuticals

CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.

Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.